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143 operations: 85 were carotid subclavian reconstructions, 22 were carotid
crossover bypasses, 30 were subclavian carotid reconstructions and 6 were
carotid subclavian transpositions. Sixty (42%) were male, 20 (14%) were
diabetic, and 63 (44%) were current smokers. Mean age was 63 (SD /
12.3). Indication for surgery was primarily for occlusive or embolic disease
(97%). In those patients undergoing bypass graft, prosthetic (ePTFE) was
used in 93%. Follow-up was performed at 3 and 6 month intervals by
ultrasound and pulse volume recordings where indicated. Life table analyses
were used to analyze patency.
Results: Of the 143 reconstructions operative mortality was 1 (0.7%).
Non-fatal complications included 3 (2.1%) for bleeding, 1 (0.7%) wound
infection, 2 (1.4%) TIA, 1 (0.7%) suffered a non-fatal stroke, 2 (1.4%) had
postoperative myocardial infarctions, and 6 (4.3%) late (30-day) occlu-
sions. Follow-up was 1 to 124 months (mean: 39 months). Primary patency
at 1 year was 98%, 3 years 96%, and 5 years was 92%.
Conclusion: Extra-anatomic arch reconstruction can be performed
safely and appears to be durable over long term follow-up. Its use with
endovascular grafting should provide a durable reconstruction for patients
who require aortic “debranching” prior endovascular thoracic aortic aneu-
rysm repair.
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Objectives: Spinal cord ischemia remains a devastating complication
after thoracic aortic surgery. The aim of this study was to investigate the
pathophysiology of spinal cord ischemia after thoracic aortic endografting
and the role of intercostal artery blood supply for the spinal cord in a
standardized animal model.
Methods: Female merino sheep were randomized to either I, open
thoracotomywith cross-clamping of the descending aorta for 50 min (n7),
II, endograft implantation (TAG, WL Gore & Ass.), (n6) or III open
thoracotomywith clipping of all intercostal arteries (n5) . CT-angiography
was used to assess completion of surgical protocol and assess the fate of
intercostal arteries. Tarloy score was used for daily neurological examination
for up to 7 days post-operatively. Histological cross sections of the lumbar,
thoracic and cervical spinal cords were scored for ischemic damage after
stained with Hematoxylin-Eosin, Klüver-Barrrera and antibodies. Exact
Kruskall-Wallis-Test was used for statistical assessment (p0.05).
Results: Incidence of paraplegia was 100% in group I and 0% in group
II (p0.0004). When compared to the endovascular group, there was a
higher rate of histological changes associated with spinal cord ischemia in the
animals of the control group (p0.0096). Group III animals showed no
permanent neurological deficit and only 20% infarction rate (p0.0318
compared to group I).
Conclusions: In sheep, incidence of histological and clinical ischemic
injury of the spinal cord following endografting was very low. Complete
thoracic aortic stent-grafting was feasible without permanent neurologic
deficit. Following endovascular coverage or clipping of their origins, there is
retrograde filling of the intercostal arteries which remain patent.
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Objective and design: In order to evaluate the comparative efficacy
and safety of carotid angioplasty with or without stent placement (CAS)
versus carotid endarterectomy (CEA) we performed a meta-analysis of the
presently available randomized studies.
Materials and methods: A multiple electronic health database search
on all randomized trials describing CAS compared with CEA in patients with
symptomatic or asymptomatic carotid artery stenosis was performed.
Results: Seven trials totalling 2972 patients (1480 randomized to CEA
and 1492 randomized to CAS) were included in the meta-analysis. Results
significantly favoured CEA over CAS in terms of death or any stroke at 30
days after procedure; the risk of death, any stroke, or myocardial infarction at
30 days; ipsilateral ischaemic stroke at 30 days; any stroke at 30 days; death
or stroke at 6 months; and the risk of procedural failure.
There was a significantly reduced risk of cranial neuropathy at 30 days
after CAS. There was no significant difference between CAS and CEA
groups in the odds of death or disabling stroke at 30 days, death or stroke at
1 year after the procedure, and ipsilateral intracerebral bleeding at 30 days.
Conclusions:The results of this meta-analysis suggest that CEA can be
performed with more safety than CAS. As a result, CEA remains the “gold
standard” treatment for suitable de novo carotid stenosis and CAS should
only be performed within randomized trials of stenting versus surgery.
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